SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-003858
Filing Date
2024-03-25
Accepted
2024-03-25 17:25:17
Documents
16
Period of Report
2024-03-25
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20240325x8k.htm   iXBRL 8-K 36520
2 EX-99.1 ampe-20240325xex99d1.htm EX-99.1 12802
3 GRAPHIC ampe-20240325xex99d1001.jpg GRAPHIC 4827
  Complete submission text file 0001558370-24-003858.txt   202994

Data Files

Seq Description Document Type Size
4 EX-101.SCH ampe-20240325.xsd EX-101.SCH 3645
5 EX-101.LAB ampe-20240325_lab.xml EX-101.LAB 19420
6 EX-101.PRE ampe-20240325_pre.xml EX-101.PRE 13534
19 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20240325x8k_htm.xml XML 4858
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 24780228
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)